PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Children\'s Tumor Foundation, New York, NY, USA. hradtke@ctf.org.\', \'Medical College of Wisconsin, Milwaukee, WI, USA. hradtke@ctf.org.\', \'University of WI - Milwaukee, Milwaukee, WI, USA.\', \'Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, USA.\', \'Children\'s Tumor Foundation, New York, NY, USA.\', \'Boston Children\'s Hospital, Boston, MA, USA.\', \'Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Massachusetts General Hospital, Boston, MA, USA.\', \'University of Alabama At Birmingham, Birmingham, AL, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13023-021-01711-w
?:doi
?:hasPublicationType
?:journal
  • Orphanet journal of rare diseases
is ?:pmid of
?:pmid
?:pmid
  • 33522938
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.413
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all